Clinical Features and Long-Term Outcomes in Very Young Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries
Table 2
Laboratory parameters and quantitative variables.
Variables
oCAD (n = 250)
MINOCA (n = 32)
Controls (n = 126)
value oCAD vs controls
value MINOCA vs controls
value oCAD vs MINOCA
Total cholesterol (mg/dl)
203.0 ± 55.4
191.4 ± 35.4
179.6 ± 40.3
<0.001
0.146
0.683
LDL cholesterol (mg/dl)
132.2 ± 51.4
118.3 ± 32.6
110.9 ± 32.3
0.001
0.314
0.431
HDL cholesterol (mg/dl)
38.3 ± 10.4
39.0 ± 10.2
43.4 ± 12.3
0.001
0.085
1.000
Triglycerides (mg/dl)
162.1 ± 109.8
182.2 ± 91.0
138.1 ± 83.0
0.153
0.013
0.904
Creatinine (mg/dl)
1.05 ± 1.1
0.92 ± 0.2
1.54 ± 2.4
0.027
0.010
1.000
Glucose (mg/dl)
107.4 ± 41.4
101.6 ± 23.4
102.3 ± 45.9
0.892
0.935
1.000
LVEF (%)
54.4 ± 8.8
58.9 ± 8.7
56.7 ± 10.8
0.378
0.320
0.111
Hospitalization days
7.3 ± 7.4
7.3 ± 6.6
5.1 ± 8.5
0.038
0.476
1.000
Data are given as mean ± SD. oCAD, obstructive coronary artery disease. CAD, coronary artery disease. HDL, high-density lipoproteins. LDL, low-density lipoproteins. LVEF, left ventricle ejection fraction.
